<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00580671</url>
  </required_header>
  <id_info>
    <org_study_id>75185</org_study_id>
    <secondary_id>5R01DA015186-07</secondary_id>
    <secondary_id>5R01DA015186-08</secondary_id>
    <nct_id>NCT00580671</nct_id>
  </id_info>
  <brief_title>Treatment for Adolescent Marijuana Abuse</brief_title>
  <official_title>Behavioral Treatment of Adolescent Marijuana Use</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dartmouth-Hitchcock Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Dartmouth-Hitchcock Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Marijuana remains the most prevalent illicit substance used by adolescents and the number of
      adolescents receiving treatment for marijuana abuse more than tripled during the last decade.
      A small number of clinical trials suggest that family-based and individual interventions have
      efficacy for treating adolescent substance abuse. However, even with these interventions most
      adolescents fail to reduce their substance use substantially, thus, there remains much room
      for improvement of treatment services. The overarching goal of this project is to develop and
      test novel behavioral treatments to enhance treatment outcome in this important treatment
      population, and in so doing, learn more about mechanisms of change that have broader
      implications for addiction science. In our initial Stage IB project &quot;Behavioral Treatment for
      Adolescent Marijuana Abuse&quot;, we created, manualized, and pilot tested a unique
      contingency-management (CM) intervention that combined abstinence-based voucher incentives
      with contingency management training for parents. A small randomized, clinical trial provided
      encouraging results. When added to a commonly used cognitive-behavior therapy, CM improved
      rates of sustained abstinence during treatment. Adolescents receiving this intervention were
      less likely to relapse over the 9-month follow-up period, however this finding was not as
      robust as the observed during treatment effects, most likely due to the small sample size and
      associated low power to detect effects. Despite strong indicators of the efficacy of this CM
      intervention, there remained room for improvement in increasing rates of treatment response
      and reducing rates of relapse. Hypothesized mediators and moderators of change indicated that
      changes in parenting had direct effects on post-treatment marijuana abstinence outcomes, and
      that abstinence early in treatment was a robust predictor of the CM treatment effect. This
      proposal will systematically replicate and extend these findings. A Stage II trial will
      compare three treatment conditions: (1) cognitive behavior therapy (CBT only); (2) CBT plus
      CM; and (3) CBT plus an enhanced CM model targeting increased early abstinence rates,
      parenting skills, and maintenance of effects. Replicating the initial demonstration of the
      positive effects of CM will extend the scientific evidence for use of CM to increase
      treatment efficacy for substance-abusing adolescents. Testing an enhanced CM model will
      determine if modifications that are consistent with the underlying behavioral principles and
      empiricism supporting CM interventions can result in improved outcomes. Last, assessment of
      potential mechanisms of action, particularly parenting, adolescent psychopathology and
      impulsivity, will provide scientific information directly relevant to future development of
      more effective intervention and prevention models of adolescent substance abuse, and will
      inform us about fundamental mechanisms operating in drug-dependence.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Marijuana Abstinence (2 Weeks or Greater)</measure>
    <time_frame>Testing done twice weekly for 14 weeks.</time_frame>
    <description>Percentage of participants who achieved 2 continuous weeks of marijuana abstinence as verified by twice weekly urine testing during the 14 weeks of treatment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Marijuana Abstinence (4 Weeks or Greater)</measure>
    <time_frame>Twice weekly urine tests for 14 weeks.</time_frame>
    <description>Percentage of participants who achieved 4 continuous weeks of marijuana abstinence as verified by twice weekly urine testing during the 14 weeks of treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of Days of Marijuana Abstinence Across All Days of Treatment (14 Weeks)</measure>
    <time_frame>This is for the proportion of days abstinent across the entire 14-week treatment period. Self-report data are collected twice weekly during treatment to obtain a cumulative proportion</time_frame>
    <description>This reflects the mean proportion of days of marijuana abstinence for each participant</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">153</enrollment>
  <condition>Marijuana Abuse</condition>
  <arm_group>
    <arm_group_label>MET/CBT+CM/BPT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Integrated psychosocial counseling. 14 weekly session. Twice weekly urine testing. Abstinence-based incentives based on urine test results. 14 weekly behavioral parenting sessions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MET/CBT+CM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Integrated psychosocial counseling. 14 weekly sessions. Twice weekly urine testing. Abstinence-based incentives based on urine test results.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MET/CBT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Integrated psychosocial counseling. 14 weekly sessions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>MET/CBT</intervention_name>
    <description>Weekly Individual Counseling Sessions</description>
    <arm_group_label>MET/CBT+CM/BPT</arm_group_label>
    <arm_group_label>MET/CBT+CM</arm_group_label>
    <arm_group_label>MET/CBT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CM</intervention_name>
    <description>Abstinence-based incentives delivered contingent on drug-negative urine test results.</description>
    <arm_group_label>MET/CBT+CM/BPT</arm_group_label>
    <arm_group_label>MET/CBT+CM</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>BPT</intervention_name>
    <description>Behavioral parent training involve 14 weekly counseling curriculum to improve parenting skills.</description>
    <arm_group_label>MET/CBT+CM/BPT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  12 to 18 years old (if 18, they must attend high school and live at home)

          -  Report using marijuana during the previous 30 days or provide a marijuana- positive
             urine test

          -  Meet criteria for cannabis abuse or dependence

          -  Have a parent/guardian who can participate

          -  Live within a 30-minute driving range from the clinic

        Exclusion Criteria:

          -  Currently meet DSM criteria for dependence on alcohol or other illicit drugs other
             than marijuana (use/abuse of other drugs will not be excluded)

          -  Exhibit active psychosis

          -  Have severe medical or psychiatric illness limiting participation

          -  Are pregnant or breast-feeding (youth only)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alan J Budney, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dartmouth College</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Geisel School of Medicine at Dartmouth</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Kamon J, Budney A, Stanger C. A contingency management intervention for adolescent marijuana abuse and conduct problems. J Am Acad Child Adolesc Psychiatry. 2005 Jun;44(6):513-21.</citation>
    <PMID>15908833</PMID>
  </reference>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 21, 2007</study_first_submitted>
  <study_first_submitted_qc>December 26, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 27, 2007</study_first_posted>
  <results_first_submitted>March 25, 2013</results_first_submitted>
  <results_first_submitted_qc>June 4, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 5, 2013</results_first_posted>
  <last_update_submitted>July 30, 2015</last_update_submitted>
  <last_update_submitted_qc>July 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 20, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dartmouth-Hitchcock Medical Center</investigator_affiliation>
    <investigator_full_name>Alan J. Budney</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Adolescent Marijuana Abuse</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Marijuana Abuse</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment opened in November 2007 and closed in February 2011. Participants were referred to the study for substance abuse treatment by school administrators, the juvenile justice system, community therapists, physicians or were self-referred. The study took place at an outpatient psychiatry clinic.</recruitment_details>
      <pre_assignment_details>Clients were enrolled into the study and assessed for eligibility, if eligible they were given the choice to proceed. Reasons for ineligibility included no marijuana (MJ) use in past 30 days, failure to meet MJ abuse/dependence criteria, met dependence for another substance, no parent participant, plans to move away, low IQ</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>MET/CBT+CM/BPT</title>
          <description>Motivational Enhancement Therapy (MET)/ Cognitive Behavior Therapy (CBT) + Contingency Management (CM) / Behavioral Parent Training (BPT)</description>
        </group>
        <group group_id="P2">
          <title>MET/CBT+CM</title>
          <description>Motivational Enhancement Therapy (MET)/CBT+CM</description>
        </group>
        <group group_id="P3">
          <title>MET/CBT</title>
          <description>Motivational Enhancement Therapy (MET)/CBT</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
                <participants group_id="P2" count="51"/>
                <participants group_id="P3" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="35"/>
                <participants group_id="P3" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="16"/>
                <participants group_id="P3" count="17"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>MET/CBT+CM/BPT</title>
          <description>Motivational Enhancement Therapy (MET)/CBT+CM/BPT</description>
        </group>
        <group group_id="B2">
          <title>MET/CBT+CM</title>
          <description>Motivational Enhancement Therapy (MET)/CBT+CM</description>
        </group>
        <group group_id="B3">
          <title>MET/CBT</title>
          <description>Motivational Enhancement Therapy (MET)/CBT</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="51"/>
            <count group_id="B2" value="51"/>
            <count group_id="B3" value="51"/>
            <count group_id="B4" value="153"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="51"/>
                    <measurement group_id="B4" value="153"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15.8" spread="1.4"/>
                    <measurement group_id="B2" value="15.9" spread="1.3"/>
                    <measurement group_id="B3" value="15.7" spread="1.3"/>
                    <measurement group_id="B4" value="15.8" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="47"/>
                    <measurement group_id="B4" value="136"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="51"/>
                    <measurement group_id="B4" value="153"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Marijuana Abstinence (2 Weeks or Greater)</title>
        <description>Percentage of participants who achieved 2 continuous weeks of marijuana abstinence as verified by twice weekly urine testing during the 14 weeks of treatment.</description>
        <time_frame>Testing done twice weekly for 14 weeks.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>MET/CBT+CM/BPT</title>
            <description>Motivational Enhancement Therapy (MET)/CBT+CM/BPT</description>
          </group>
          <group group_id="O2">
            <title>MET/CBT+CM</title>
            <description>Motivational Enhancement Therapy (MET)/CBT+CM</description>
          </group>
          <group group_id="O3">
            <title>MET/CBT</title>
            <description>Motivational Enhancement Therapy (MET)/CBT</description>
          </group>
        </group_list>
        <measure>
          <title>Marijuana Abstinence (2 Weeks or Greater)</title>
          <description>Percentage of participants who achieved 2 continuous weeks of marijuana abstinence as verified by twice weekly urine testing during the 14 weeks of treatment.</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="51"/>
                <count group_id="O3" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.5"/>
                    <measurement group_id="O2" value="68.6"/>
                    <measurement group_id="O3" value="45.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Proportion of Days of Marijuana Abstinence Across All Days of Treatment (14 Weeks)</title>
        <description>This reflects the mean proportion of days of marijuana abstinence for each participant</description>
        <time_frame>This is for the proportion of days abstinent across the entire 14-week treatment period. Self-report data are collected twice weekly during treatment to obtain a cumulative proportion</time_frame>
        <population>Those participants with data on at least 80 days of the 91 days of treatment were used in this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>MET/CBT+CM/BPT</title>
            <description>Motivational Enhancement Therapy (MET)/CBT+CM/BPT</description>
          </group>
          <group group_id="O2">
            <title>MET/CBT+CM</title>
            <description>Motivational Enhancement Therapy (MET)/CBT+CM</description>
          </group>
          <group group_id="O3">
            <title>MET/CBT</title>
            <description>Motivational Enhancement Therapy (MET)/CBT</description>
          </group>
        </group_list>
        <measure>
          <title>Proportion of Days of Marijuana Abstinence Across All Days of Treatment (14 Weeks)</title>
          <description>This reflects the mean proportion of days of marijuana abstinence for each participant</description>
          <population>Those participants with data on at least 80 days of the 91 days of treatment were used in this analysis.</population>
          <units>proportion of marijuana abstinent days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".8058" spread=".29419"/>
                    <measurement group_id="O2" value=".8162" spread=".29143"/>
                    <measurement group_id="O3" value=".7915" spread=".26115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Marijuana Abstinence (4 Weeks or Greater)</title>
        <description>Percentage of participants who achieved 4 continuous weeks of marijuana abstinence as verified by twice weekly urine testing during the 14 weeks of treatment.</description>
        <time_frame>Twice weekly urine tests for 14 weeks.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>MET/CBT+CM/BPT</title>
            <description>Motivational Enhancement Therapy (MET)/CBT+CM/BPT</description>
          </group>
          <group group_id="O2">
            <title>MET/CBT+CM</title>
            <description>Motivational Enhancement Therapy (MET)/CBT+CM</description>
          </group>
          <group group_id="O3">
            <title>MET/CBT</title>
            <description>Motivational Enhancement Therapy (MET)/CBT</description>
          </group>
        </group_list>
        <measure>
          <title>Marijuana Abstinence (4 Weeks or Greater)</title>
          <description>Percentage of participants who achieved 4 continuous weeks of marijuana abstinence as verified by twice weekly urine testing during the 14 weeks of treatment.</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="51"/>
                <count group_id="O3" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.8"/>
                    <measurement group_id="O2" value="64.7"/>
                    <measurement group_id="O3" value="35.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>MET/CBT+CM/BPT</title>
          <description>Motivational Enhancement Therapy (MET)/CBT+CM/BPT</description>
        </group>
        <group group_id="E2">
          <title>MET/CBT+CM</title>
          <description>Motivational Enhancement Therapy (MET)/CBT+CM</description>
        </group>
        <group group_id="E3">
          <title>MET/CBT</title>
          <description>Motivational Enhancement Therapy (MET)/CBT</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="51"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="51"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Boot Camp, Detention, Incarceration</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="51"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="51"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Residential Treatment for Substance Use</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="51"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="51"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Hospitatlization or Residential Treatment for Mental Health</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="51"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="51"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1.96</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="51"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="51"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Arrested</sub_title>
                <description>Arrest not resulting in boot camp, detention, or incarceration</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="51"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="51"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Running Away</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="51"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="51"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Expelled from School</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="51"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="51"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Dropped Out of School</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="51"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>DCFS Report</sub_title>
                <description>Report made to the department of children and family services (DCFS)</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Alan J. Budney, PhD</name_or_title>
      <organization>Geisel School of Medicine at Dartmouth</organization>
      <phone>855-290-2822</phone>
      <email>alan.j.budney@dartmouth.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

